Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Pharmaceuticals

November 16, 2020 — Among patients who stopped taking their cholesterol-lowering statin medication due to side effects ...

Home November 16, 2020
Home
News | Pharmaceuticals

November 16, 2020 — Novartis announced results from two pooled post-hoc analyses of Phase III ORION-9, -10 and -11 ...

Home November 16, 2020
Home
News | Coronavirus (COVID-19) | Dave Fornell, Editor

November 9, 2020 — A National Institutes of Health (NIH) clinical trial evaluating the safety and effectiveness of hydro ...

Home November 09, 2020
Home
The American Heart Association, AHA, late-breaking sessions, trials, studies. #AHA #AHA20 #AHA2020
Feature | AHA | Dave Fornell, Editor

Here is a list of the American Heart Association (AHA) late-breaking clinical trial presentations at the 2020 Virtual ...

Home November 20, 2020
Home
Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the  Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip. Acurate neo TAVR valve. #TCTconnect #TCT2020
Feature | TCT | Dave Fornell, Editor

Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials ...

Home October 29, 2020
Home
News | Atrial Fibrillation

Oct. 29, 2020 — Boston Scientific initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the ...

Home October 29, 2020
Home
Videos | Antiplatelet and Anticoagulation Therapies

The COMPARE CRUSH Trial looked at the effect of per-hospital crushed prasugrel tablets in patients with STEMI planned ...

Home October 19, 2020
Home
Videos | Antiplatelet and Anticoagulation Therapies

Gregg Stone, M.D., presents the results of a pooled analysis of randomized trials of bivalirudin virus heparin in acute ...

Home October 17, 2020
Home
News | Stents Drug Eluting

October 16, 2020 – Results from the XIENCE 90/28 clinical trials have shown that a shorter course of dual-antiplatelet ...

Home October 16, 2020
Home
News | Stents

October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual ...

Home October 01, 2020
Home
News | Coronavirus (COVID-19)

September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients ...

Home September 25, 2020
Home
News | Coronavirus (COVID-19)

September 24, 2020 — Analyzing anonymized patient medical records, University of California (UC) San Diego Health resear ...

Home September 24, 2020
Home
News | Coronavirus (COVID-19)

September 17, 2020 — Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of C ...

Home September 17, 2020
Home
News | Coronavirus (COVID-19)

September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials ...

Home September 11, 2020
Home
Subscribe Now